๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tuberculosis in Liver Transplant Recipients: Prophylaxis in an Endemic Area

โœ Scribed by L. Agoglia; E. Balbi; M. Halpern; J. Roma; L. Carius; J.M. Martinho; L.P. Moreira


Book ID
113934964
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
221 KB
Volume
43
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Tuberculosis in liver transplant recipie
โœ Olithselvan, Arikichenin; Jothimani, Dinesh; Shanmugam, Vivekanandan; Narashimha ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Elsevier ๐ŸŒ English โš– 63 KB
Antifungal prophylaxis in liver transpla
โœ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Erratum: Antifungal prophylaxis in liver
โœ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB

UNOS status 4 (life support in ICU) 146 6.3 (2.4-16.7) George 1997 ( 14 ) Donor CMV รพ/recipient -146 4.8 (2.0-11.8) George 1997 ( 14 ) UNOS class I (life support in ICU) 172 3.5 (1.7-7.0) Winston 1999 ( 23 ) Fungal colonization at baseline 172 2.3 (1.2-4.3) Winston 1999 ( 23 ) Pretransplant SCr 3 mg

Valganciclovir for cytomegalovirus proph
โœ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur